Edition:
India

Sino Biopharmaceutical Ltd (1177.HK)

1177.HK on Hong Kong Stock

7.66HKD
21 May 2019
Change (% chg)

HK$-0.16 (-2.05%)
Prev Close
HK$7.82
Open
HK$7.74
Day's High
HK$7.80
Day's Low
HK$7.60
Volume
49,500,989
Avg. Vol
64,028,547
52-wk High
HK$13.93
52-wk Low
HK$4.53

Latest Key Developments (Source: Significant Developments)

Sino Biopharmaceutical Says Drug Developed By Unit Gets Approval For Drug Registration
Thursday, 9 May 2019 

May 9 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::'AMBRISENTAN TABLET' DEVELOPED BY UNIT GETS APPROVAL FOR DRUG REGISTRATION BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF PRC.  Full Article

Sino Biopharmaceutical Says Drug Developed By Unit Received Approval For Registration
Wednesday, 9 Jan 2019 

Jan 9 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::LINEZOLID & GLUCOSE INJECTION OF UNIT RECEIVED APPROVAL FOR DRUG REGISTRATION BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION.  Full Article

Sino Biopharmaceutical Updates On Price And Volume Movements Of Shares Of Co
Thursday, 6 Dec 2018 

Dec 6 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::TWO PRODUCTS OF GROUP ARE SUCCESSFUL BIDDERS IN TENDER FOR CENTRALISED PROCUREMENT OF MEDICINES IN PILOT CITIES OF CHINA.SAVE AS DISCLOSED, NOT AWARE OF ANY REASONS FOR PRICE OR VOLUME MOVEMENTS OF SHARES OF CO.  Full Article

Sino Biopharmaceutical Says Iodixanol Injection Obtained Approval For Drug Registration
Tuesday, 3 Jul 2018 

July 3 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::IODIXANOL INJECTION OBTAINED APPROVAL FOR DRUG REGISTRATION BY NATIONAL DRUG ADMINISTRATION OF PRC.  Full Article

Sino Biopharmaceutical Updates On Further Share Purchase By Trustee
Wednesday, 27 Jun 2018 

June 27 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::DURING PERIOD FROM 5 JUNE TO 7 JUNE TRUSTEE FURTHER PURCHASED 7.3 MILLION SHARES AT AVERAGE CONSIDERATION HK$13.04 PER SHARE.  Full Article

Sino Biopharmaceutical Says FY Profit Attributable Up 32.6 Pct
Friday, 23 Mar 2018 

March 23 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::‍RECOMMENDED PAYMENT OF A FINAL DIVIDEND OF HK2 CENTS PER SHARE FOR YEAR​.FY PROFIT ATTRIBUTABLE TO OWNERS OF PARENT WAS RMB2,170.95 MILLION, UP 32.6%.FY REVENUE OF APPROXIMATELY RMB14,819.30 MILLION, AN INCREASE OF APPROXIMATELY 9.4%.  Full Article

Sino Biopharmaceutical Co Announces Acquisition of Sino Biopharm Beijing​ & Super Demand
Friday, 5 Jan 2018 

Jan 5 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::CO TO ACQUIRE SINO BIOPHARM BEIJING​,WHICH OWNS 33.6% OF BEIJING TIDE, BY ISSUING 723.3 MILLION SHARES AT HK$12.73 PER ISSUE SHARE.‍FRANCE INVESTMENT (CHINA 1) GROUP TO SELL 52 PERCENT STAKE IN SUPER DEMAND FOR HK$3.69 BILLION TO CO ​.  Full Article

Sino Biopharmaceutical Product Granted Drug Registration Approval By State FDA Of China​
Tuesday, 5 Dec 2017 

Dec 5 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::"TENOFOVIR DISOPROXIL FUMARATE TABLET" GRANTED DRUG REGISTRATION APPROVAL BY STATE FOOD AND DRUG ADMINISTRATION OF CHINA​.‍TENOFOVIR DISOPROXIL FUMARATE GRANTED APPROVAL FOR TREATMENT OF CHRONIC HEPATITIS B​.  Full Article

Sino Biopharmaceutical posts 9-month ‍net profit attributable of RMB1.80​ bln
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK> ::9-month ‍revenue RMB11,446.73 million, up 9.5​ percent.‍Declared payment of a third quarterly dividend of HK2 cents per share for three months ended 30 Sept​.9-month net profit attributable to owners RMB1.80​ billion versus RMB1.30 billion.  Full Article

Sino Biopharmaceutical posts HY revenue of about RMB7,482.86 mln
Monday, 21 Aug 2017 

Aug 21 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>:HY revenue was approximately RMB7,482.86 million, an increase of approximately 10.6 percent.Board of directors of company declared payment of a second quarterly dividend of HK2 cents per share.Before accounting for unrealized fair value gains & losses of equity investments & financial assets, HY net profit about RMB1,076.34 million.  Full Article

Hong Kong shares end lower as Huawei charges fan trade worries

* HSI financial sector sub-index is flat; property sector up 0.5 percent